Missed opportunities in secondary prevention with statins

Heart. 2023 Feb 14;109(5):340-341. doi: 10.1136/heartjnl-2022-321855.
No abstract available

Keywords: Coronary Artery Disease; Drug Monitoring; Medication Adherence; Peripheral Vascular Diseases; Quality of Health Care.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use
  • Medication Adherence
  • Secondary Prevention

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors